Poseida Therapeutics Inc. (PSTX) Social Stream
POSEIDA THERAPEUTICS INC (PSTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering POSEIDA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-13 | 4 | $40 | $19 | $26.333 | $3.17 | 730.69% |
| 2022-01-12 | 5 | $40 | $19 | $25.75 | $3.17 | 712.3% |
| 2022-03-11 | 4 | $40 | $12 | $23.666 | $3.17 | 646.56% |
| 2022-05-13 | 5 | $40 | $12 | $23.75 | $3.17 | 649.21% |
| 2022-05-16 | 5 | $24 | $9 | $16.25 | $3.17 | 412.62% |
| 2022-08-03 | 4 | $24 | $9 | $16.25 | $3.17 | 412.62% |
| 2022-09-17 | 4 | $24 | $11 | $16.75 | $3.17 | 428.39% |
| 2022-12-01 | 4 | $24 | $10 | $14.75 | $3.17 | 365.3% |
| 2023-03-10 | 5 | $24 | $10 | $14.8 | $3.17 | 366.88% |
| 2023-07-11 | 5 | $17 | $10 | $13.4 | $3.17 | 322.71% |
| 2023-08-07 | 5 | $17 | $8 | $12.8 | $3.17 | 303.79% |
| 2023-11-09 | 5 | $15 | $8 | $12.2 | $3.17 | 284.86% |
| 2023-11-10 | 5 | $15 | $8 | $11.75 | $3.17 | 270.66% |
| 2023-12-11 | 5 | $20 | $10 | $13.333 | $3.17 | 320.6% |
The Trend in the Analyst Price Target
PSTX's average price target has moved down $1.47 over the prior 45 weeks.
Over the past 45 weeks, PSTX's average upside potential has been 338.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 5 | 17 | 10 | 13.400 | 2.91 | 360.48% |
| 2023-05-19 | 5 | 17 | 10 | 13.400 | 2.58 | 419.38% |
| 2023-11-09 | 5 | 15 | 8 | 12.200 | 2.20 | 454.55% |
| 2023-11-10 | 5 | 15 | 8 | 11.750 | 2.19 | 436.53% |
| 2023-12-11 | 5 | 20 | 10 | 13.333 | 2.85 | 367.82% |
PSTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 41 months, PSTX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how POSEIDA THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1388.61% of that group.
- To contextualize these metrics, consider that out of all US stocks, POSEIDA THERAPEUTICS INC's number of analysts covering the stock is greater than 269.8% of them.
- PSTX has a lower variance in analysts' estimates than -1102.7% of all US stocks.
- PSTX has a greater average analyst price target than 306.34% of all US stocks.
Stocks similar to POSEIDA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TARS, SABS, and MOLN.
View All Top Stocks by Price Target
Make investment decisions regarding PSTX using the data that counts. Try POWR Ratings for free.